Aligning Cancer Clinical Trials With Cancer Burden: Need for Greater Global Leadership, Resources, and Vision

Aakash Desai^{1

2}, Nicole M Kuderer³, Gary H Lyman^{4

5}

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
² Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
³ Advanced Cancer Research Group, Seattle, Washington.
⁴ Divisions of Public Health Sciences and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
⁵ Division of Oncology, Department of Medicine, University of Washington, Seattle.

Editorial

Aakash Desai et al. JAMA Oncol. 2021.

. 2021 Mar 1;7(3):357-358.

doi: 10.1001/jamaoncol.2020.7293.

Aakash Desai^{1

2}, Nicole M Kuderer³, Gary H Lyman^{4

5}

¹ Division of Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
² Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
³ Advanced Cancer Research Group, Seattle, Washington.
⁴ Divisions of Public Health Sciences and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
⁵ Division of Oncology, Department of Medicine, University of Washington, Seattle.

No abstract available

Comment on

An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
Wells JC, Sharma S, Del Paggio JC, Hopman WM, Gyawali B, Mukherji D, Hammad N, Pramesh CS, Aggarwal A, Sullivan R, Booth CM. Wells JC, et al. JAMA Oncol. 2021 Mar 1;7(3):379-385. doi: 10.1001/jamaoncol.2020.7478. JAMA Oncol. 2021. PMID: 33507236 Free PMC article.